Trill AB

10% OwnerDiaMedica Therapeutics Inc. (DMAC) · full profile →Form 4 · filed Dec 8, 2025
Net Buying
Open-Market Buys
$7.6M
Open-Market Sells
$0
Net Open-Market Flow
$7.6M
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Buy(P)73K$8.57$626K8.8M
Nov 24, 2025Buy(P)40K$7.89$318K8.8M
Nov 21, 2025Buy(P)209K$7.41$1.5M8.7M
Nov 20, 2025Buy(P)128K$7.41$952K8.5M
Nov 19, 2025Buy(P)240K$7.21$1.7M8.4M
Nov 18, 2025Buy(P)183K$6.75$1.2M8.1M
Nov 17, 2025Buy(P)187K$6.52$1.2M8.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-119360) within minutes of acceptance. Every field above traces to the original document. Verify it directly: